MKZR to mail letters; Board approves Q4 2025 preferred payouts
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
MacKenzie Realty Capital (MKZR) reported two updates. First, the company will mail letters to its Series A, B, and C preferred stockholders on October 15, 2025, with the letters furnished as Exhibits 99.1, 99.2, and 99.3. Second, the Board approved the regular dividends for the quarter ending December 31, 2025 for the Series A, Series B, and Series C Preferred shares. The communication was furnished under Regulation FD and includes forward‑looking statements.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 7.01, 8.01, 9.01
3 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did MKZR announce in this 8-K?
The company will mail letters to Series A, B, and C preferred stockholders on October 15, 2025 and the Board approved regular dividends for the quarter ending December 31, 2025 for those series.
Which securities are affected by the updates from MKZR?
The updates pertain to Series A, Series B, and Series C Preferred shares.
What period do the approved preferred dividends cover for MKZR (MKZR)?
The Board approved regular dividends for the quarter ending December 31, 2025.
Are the stockholder letters available to view?
Yes. The letters are included as exhibits: 99.1 (Series A), 99.2 (Series B), and 99.3 (Series C).
Under which items were these disclosures made?
The mailing of letters was furnished under Item 7.01 (Regulation FD), and the dividend approval was disclosed under Item 8.01 (Other Events).
What is MKZR’s trading symbol and exchange?
The common stock trades under MKZR on NASDAQ.